142 related articles for article (PubMed ID: 15452087)
1. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
Franklin AJ; Jetton TL; Kuchemann CL; Russell SR; Kohn EC
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3756-66. PubMed ID: 15452087
[TBL] [Abstract][Full Text] [Related]
2. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
Elner SG; Elner VM; Yoshida A; Dick RD; Brewer GJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):299-303. PubMed ID: 15623788
[TBL] [Abstract][Full Text] [Related]
3. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy.
Stitt AW; McKenna D; Simpson DA; Gardiner TA; Harriott P; Archer DB; Nelson J
Am J Pathol; 1998 May; 152(5):1359-65. PubMed ID: 9588904
[TBL] [Abstract][Full Text] [Related]
4. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation of STAT3 in ischemia-induced retinopathy.
Mechoulam H; Pierce EA
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4409-16. PubMed ID: 16303927
[TBL] [Abstract][Full Text] [Related]
6. Squalamine improves retinal neovascularization.
Higgins RD; Sanders RJ; Yan Y; Zasloff M; Williams JI
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1507-12. PubMed ID: 10798670
[TBL] [Abstract][Full Text] [Related]
7. Altered retinal neovascularization in TNF receptor-deficient mice.
Ilg RC; Davies MH; Powers MR
Curr Eye Res; 2005 Nov; 30(11):1003-13. PubMed ID: 16282134
[TBL] [Abstract][Full Text] [Related]
8. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
9. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
[TBL] [Abstract][Full Text] [Related]
10. Calcitriol is a potent inhibitor of retinal neovascularization.
Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298
[TBL] [Abstract][Full Text] [Related]
11. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy.
Taomoto M; McLeod DS; Merges C; Lutty GA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625
[TBL] [Abstract][Full Text] [Related]
12. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
14. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
[TBL] [Abstract][Full Text] [Related]
15. [Expression and role of endostatin in the retina of oxygen-induced retinopathy mouse model].
Zhang MX; Zhang JJ; Yan M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):614-7. PubMed ID: 16909615
[TBL] [Abstract][Full Text] [Related]
16. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Fang X; Ueno M; Yamashita T; Ikuno Y
Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
[TBL] [Abstract][Full Text] [Related]
18. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model.
Akkoyun I; Karabay G; Haberal N; Dagdeviren A; Yilmaz G; Oto S; Erkanli L; Akova YA
Acta Ophthalmol; 2012 Sep; 90(6):564-70. PubMed ID: 20698831
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
Zhang M; Yang Y; Yan M; Zhang J
Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
[TBL] [Abstract][Full Text] [Related]
20. 5' nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy.
Lutty GA; Merges C; McLeod DS
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):218-29. PubMed ID: 10634624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
